Corient Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $216K | Hold |
2,707
| – | – | 0.02% | 592 |
|
2022
Q2 | $216K | Sell |
2,707
-400
| -13% | -$31.9K | 0.02% | 606 |
|
2022
Q1 | $327K | Buy |
3,107
+33
| +1% | +$3.47K | 0.02% | 509 |
|
2021
Q4 | $331K | Buy |
3,074
+87
| +3% | +$9.37K | 0.02% | 482 |
|
2021
Q3 | $327K | Buy |
2,987
+345
| +13% | +$37.8K | 0.02% | 468 |
|
2021
Q2 | $247K | Buy |
2,642
+469
| +22% | +$43.8K | 0.02% | 555 |
|
2021
Q1 | $200K | Buy |
+2,173
| New | +$200K | 0.02% | 572 |
|